Oral anticoagulation and left atrial thrombi resolution in nonrheumatic atrial fibrillation or flutter: A systematic review and meta-analysis.

Norman C WangMatthew D SatherAliza HussainAndrew D AlthouseEvan C AdelsteinSandeep K JainWilliam E KatzAlaa A ShalabyAndrew H VoigtSamir Saba

Published in: Pacing and clinical electrophysiology : PACE (2018)

Warfarin is the most studied initial OAC agent for treating LAT in nonrheumatic AF and/or AFL with a resolution rate of nearly 80%. Further studies in DOACs are warranted.

Keyphrases

atrial fibrillation
left atrial
direct oral anticoagulants
catheter ablation
oral anticoagulants
left atrial appendage
single molecule
heart failure
percutaneous coronary intervention
case control
mitral valve
acute coronary syndrome